Publikationen der ALS-Forschungsgruppe an der Charité
The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia
Meyer T, Münch C, Völkel H, Booms P, Ludolph AC.J Neurol Neurosurg
Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosis
Meyer T, Lenk U, Küther G, Weindl A, Speer A, Ludolph AC.Ann
Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der ALS
Publikation auf Journal-Website: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-2019-3500Publikation im Volltext: https://als-charite.de/wp-content/uploads/2024/12/Klinische-Neurophysiologie_PROM-bei-der-ALS-V6.0_202300802.pdf
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
Eschbach J, Schwalenstöcker B, Soyal SM,
Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis
Roth NM, Saidha S, Zimmermann H,
The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes
Stockmann M, Meyer-Ohlendorf M, Achberger K,
NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis
Blauw HM, van Rheenen W, Koppers
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients
Lee T, Li YR, Ingre C,
A large genome scan for rare CNVs in amyotrophic lateral sclerosis
Blauw HM, Al-Chalabi A, Andersen PM,
Novel missense and truncating mutations in FUS/TLS in familial ALS
Waibel S, Neumann M, Rabe M,
No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort
Fernández-Santiago R, Sharma M, Berg D,
